These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 332684)

  • 1. Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria.
    Burman LG
    J Antimicrob Chemother; 1977 Sep; 3(5):509-16. PubMed ID: 332684
    [No Abstract]   [Full Text] [Related]  

  • 2. Nalidixic acid inhibits the conjugal transfer of conjugative N incompatibility group plasmids.
    Gill S; Iyer VN
    Can J Microbiol; 1982 Feb; 28(2):256-8. PubMed ID: 7039791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 4. Fosfomycin and plasmidic resistance.
    Baquero F; López-Brea M; Valls A; Cañedo T
    Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections].
    Chamfeuil R; Curcier H
    Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534
    [No Abstract]   [Full Text] [Related]  

  • 6. A new screening method for proof of R factors transfer.
    Bohus J
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):202-11. PubMed ID: 4606127
    [No Abstract]   [Full Text] [Related]  

  • 7. Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coli.
    Ambler JE; Pinney RJ
    J Antimicrob Chemother; 1995 May; 35(5):603-9. PubMed ID: 7592173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nalidixic acid: an antibacterial paradox.
    Crumplin GC; Smith JT
    Antimicrob Agents Chemother; 1975 Sep; 8(3):251-61. PubMed ID: 1101818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of the deoxyribonucleic acid of multiple-drug-resistance factor in Escherichia coli.
    Barker GR; Hardman N; Twose TM
    Biochem J; 1976 Jul; 157(1):221-7. PubMed ID: 786280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to nalidixic acid. A misconception due to underdosage.
    Stamey TA; Bragonje J
    JAMA; 1976 Oct; 236(16):1857-60. PubMed ID: 989536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
    Scazzocchio F; Selan L; Oliva B; Schippa S; Cellini L; Renzini G
    Chemioterapia; 1988 Oct; 7(5):295-7. PubMed ID: 3066516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance and R plasmids of Escherichia coli strains isolated from six species of wild birds.
    Nakamura M; Yoshimura H; Koeda T
    Nihon Juigaku Zasshi; 1982 Jun; 44(3):465-71. PubMed ID: 6752506
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.
    Crumplin GC; Smith JT
    J Antimicrob Chemother; 1981 Apr; 7(4):379-88. PubMed ID: 7019186
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the determination of nalidixic acid-resistance of R-plasmids in E. coli].
    Höhne C; Patsch R
    Zentralbl Bakteriol Orig A; 1973 Jun; 224(1):85-91. PubMed ID: 4147408
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L; Pascual A; Jacoby GA
    Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of R factors among coliform bacteria.
    Woods DR; Marcos D; Hendry DA
    S Afr Med J; 1972 Feb; 46(8):189-91. PubMed ID: 4555315
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the in vitro antibacterial activity of ofloxacin and nalidixic acid].
    Hasçelik G; Baykal M
    Mikrobiyol Bul; 1990 Jul; 24(3):251-5. PubMed ID: 2283977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].
    Uccelli V; Laporte JM; Michel-Briand Y
    C R Seances Soc Biol Fil; 1985; 179(5):696-9. PubMed ID: 2938699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.